Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01267864 · ClinicalTrials.gov registry record · Phase 4
Valproate Versus Ketorolac Versus Metoclopramide
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 330
- Enrollment target
NCT01267864 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 330 participants.
The verdict
NCT01267864, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 330 participants
- Enrollment target
Study Summary
This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.
Interventions
- DRUG Ketorolac
- DRUG Valproate
- DRUG Metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01267864
The ClinicalTrials.gov registry entry for NCT01267864 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketorolac is the first listed.
NCT01267864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01267864 about?
NCT01267864 is a clinical study titled "Valproate Versus Ketorolac Versus Metoclopramide". This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.
What is the current status of trial NCT01267864?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 330 participants. The study started on 2010-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01267864?
The interventions under investigation include: Ketorolac (DRUG), Valproate (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT01267864?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.